AI assistant
Sending…
Research Solutions, Inc. — Director's Dealing 2011
Nov 14, 2011
34019_dirs_2011-11-14_93181af4-394d-4f93-96fa-75d732d81a41.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: Derycz Scientific Inc (DYSC)
CIK: 0001386301
Period of Report: 2011-06-30
Reporting Person: Derycz Peter (Director, CEO, President, Chairman, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-01-10 | Common Stock | G | 400000 | $0.00 | Disposed | 3600000 | Direct |
| 2011-01-10 | Common Stock | G | 400000 | $0.00 | Acquired | 400000 | Indirect |
| 2011-01-10 | Common Stock | G | 4905 | $0.00 | Disposed | 3595095 | Direct |
| 2011-01-10 | Common Stock | G | 4905 | $0.00 | Acquired | 404905 | Indirect |
| 2011-01-10 | Common Stock | G | 4905 | $0.00 | Disposed | 3590190 | Direct |
| 2011-01-10 | Common Stock | G | 4905 | $0.00 | Acquired | 409810 | Indirect |
| 2011-01-10 | Common Stock | G | 4905 | $0.00 | Disposed | 3585285 | Direct |
| 2011-01-10 | Common Stock | G | 4905 | $0.00 | Acquired | 414715 | Indirect |
| 2011-01-10 | Common Stock | G | 4905 | $0.00 | Disposed | 3580380 | Direct |
| 2011-01-10 | Common Stock | G | 4905 | $0.00 | Acquired | 419620 | Indirect |
Footnotes
F1: On January 10, 2011, Mr. Derycz made the following transfers by gift: 400,000 shares of the issuer's common stock to his wife and 4,905 shares of the issuer's common stock to each of his four children. As a result of such transfers, Mr. Derycz currently owns 3,580,380 shares directly and 419,620 shares indirectly through his wife and children.
More from Research Solutions, Inc.
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Feb 13
Regulatory Filings
2026
Feb 12
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 17
Director's Dealing
2025
Dec 13
Board/Management Information
2025
Dec 11
Director's Dealing
2025
Nov 21